AGP Executive Report
Last update: 7 hours agoFood Manufacturing: Nestlé will invest another $1 billion in Mexico from 2028 to 2030, doubling its announced commitment there to $2 billion and expanding production, modernising facilities and strengthening local supply chains. Swiss Biotech: CSL signed an exclusive deal with Swiss firm Alentis Therapeutics to develop and commercialise lixudebart, a candidate for rare kidney and liver diseases. Healthcare: Galderma agreed to buy US skincare brand ZO Skin Health for $1.5 billion, adding a physician-focused brand and professional distribution network. Telecoms: Swisscom won an appeal overturning a $21.6 million fine in a fibre-optic case. Insurance: Swiss Re estimates hail caused CHF1.7 billion in damage, adding to pressure from extreme-weather claims. Aviation: Lufthansa won the bid for a 44.9% stake in TAP Air Portugal; the deal, expected to close in 2028, would extend the group that includes SWISS.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
